An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?
A positive energy balance (energy intake>energy expenditure), in which total fat intake plays an important role, is commonly regarded as a major factor contributing to obesity. Adipose tissue development, i.e. both size (hypertrophy) and number (hyperplasia), is stimulated by high dietary fat intake during early postnatal development, a susceptibility that now appears to continue well into adulthood. Recent human and animal studies suggest that by altering rates of adipocyte differentiation and proliferation, differences in the composition of dietary fat may also contribute to adipose tissue development. At least in rodent models, the relative intake of n-6 to n-3 PUFA is clearly emerging as a new factor in this development. In these models, higher linoleate intake raises tissue arachidonic acid, which increases prostacyclin production and, in turn, stimulates signalling pathways implicated in adipogenesis. Signalling pathways stimulated by arachidonic acid probably include phospholipase and/or cyclo-oxygenase activation and may be linked as much to relatively low intake of n-3 PUFA as to excessive dietary linoleate. One factor potentially contributing to oversight about the apparent role of dietary n-6 PUFA (especially excess dietary linoleate) in adipose tissue development is the historical overestimation of linoleate requirements and the enthusiasm for higher intake of 'essential fatty acids'. More research is needed to address whether disequilibration of dietary PUFA intake contributes to the risk of obesity in humans.
Ailhaud
Gérard
G
ISDBC, Université de Nice Sophia-Antipolis, CNRS, 28 avenue Valrose, Nice 06100, France. ailhaud@unice.fr
Guesnet
Philippe
P
Cunnane
Stephen C
SC
D050156:Adipogenesis / Q000502:physiology*; D001823:Body Composition; D002648:Child; D004041:Dietary Fats / Q000009:adverse effects* / Q000378:metabolism; D043371:Fatty Acids, Omega-6 / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D009765:Obesity / Q000209:etiology* / Q000378:metabolism; D012307:Risk Factors; D014481:United States
D004041:Dietary Fats; D043371:Fatty Acids, Omega-6